MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
| Autor: | Seth J. Baum, Sam E. Moussa, Rebecca Taub, Juan P. Frias, Meena B. Bansal, B. Tetri, Naim Alkhouri, Mustafa R. Bashir, Sandy P. Harrison |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Agonist
medicine.medical_specialty Hepatology medicine.diagnostic_test business.industry medicine.drug_class Thyroid hormone receptor beta 03 medical and health sciences 0302 clinical medicine Endocrinology 030220 oncology & carcinogenesis Internal medicine Liver biopsy Clinical endpoint Medicine 030211 gastroenterology & hepatology business |
| Zdroj: | Journal of Hepatology. 68:S38 |
| ISSN: | 0168-8278 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect